Repligen (RGEN) News Today $126.38 -0.88 (-0.69%) As of 12:38 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Repligen Co. (NASDAQ:RGEN) is 12 West Capital Management LP's 10th Largest Position12 West Capital Management LP lessened its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 2.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 246,875 shares of the biotechnology company's stock after sellingApril 15 at 6:57 AM | marketbeat.comRepligen Corp (RGEN) Shares Up 3% on Apr 14April 14 at 1:59 PM | gurufocus.comBessemer Group Inc. Cuts Stock Holdings in Repligen Co. (NASDAQ:RGEN)Bessemer Group Inc. cut its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 2.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 248,689 shares of the biotechnology company's stock after selling 6,50April 12 at 7:12 AM | marketbeat.comDynamic Technology Lab Private Ltd Makes New $397,000 Investment in Repligen Co. (NASDAQ:RGEN)Dynamic Technology Lab Private Ltd purchased a new position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,760 shares of the biotechnology cApril 12 at 5:09 AM | marketbeat.comRanger Investment Management L.P. Has $32.54 Million Position in Repligen Co. (NASDAQ:RGEN)Ranger Investment Management L.P. decreased its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 1.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 226,067 shares of the biotechnology compaApril 11, 2025 | marketbeat.comRepligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings?April 10, 2025 | msn.comRepligen Co. (NASDAQ:RGEN) Shares Acquired by LPL Financial LLCLPL Financial LLC increased its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 47.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,237 shares of the biotechnology company's stock afterApril 10, 2025 | marketbeat.comRepligen (RGEN) Gets a Hold from GuggenheimApril 10, 2025 | markets.businessinsider.comRepligen appoints Jacob Johnson as VP, investor relationsApril 9, 2025 | markets.businessinsider.comRepligen price target lowered to $202 from $219 at RBC CapitalApril 8, 2025 | markets.businessinsider.comRepligen Appoints Jacob Johnson As Vice President Investor RelationsApril 8, 2025 | markets.businessinsider.comRepligen Appoints Jacob Johnson As Vice President Investor RelationsApril 8, 2025 | globenewswire.comRepligen Co. (NASDAQ:RGEN) Shares Sold by California Public Employees Retirement SystemCalifornia Public Employees Retirement System reduced its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 6.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,320 shares of the biotechnApril 8, 2025 | marketbeat.comNorges Bank Takes $24.03 Million Position in Repligen Co. (NASDAQ:RGEN)Norges Bank purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 166,975 shares of the biotechnology companyApril 8, 2025 | marketbeat.comRGEN Quantitative Stock Analysis - Benjamin GrahamApril 7, 2025 | nasdaq.comRepligen (NASDAQ:RGEN) Rating Increased to Hold at StockNews.comStockNews.com raised shares of Repligen from a "sell" rating to a "hold" rating in a research report on Friday.April 6, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Reaches New 12-Month Low - Should You Sell?Repligen (NASDAQ:RGEN) Sets New 1-Year Low - Time to Sell?April 6, 2025 | marketbeat.comWestpac Banking Corp Buys 3,305 Shares of Repligen Co. (NASDAQ:RGEN)Westpac Banking Corp grew its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 17.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,725 shares of the biotechnology company's stock after purchasing an additional 3,305April 6, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Upgraded to Hold at StockNews.comApril 6, 2025 | americanbankingnews.comDF Dent & Co. Inc. Trims Stock Position in Repligen Co. (NASDAQ:RGEN)DF Dent & Co. Inc. cut its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 4.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 563,280 shares of the biotechnology company's stock after selling 27,041 sharesApril 5, 2025 | marketbeat.comExodusPoint Capital Management LP Boosts Holdings in Repligen Co. (NASDAQ:RGEN)ExodusPoint Capital Management LP raised its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 122.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 213,718 shares of the biotechnology companyApril 5, 2025 | marketbeat.comCinctive Capital Management LP Boosts Stock Position in Repligen Co. (NASDAQ:RGEN)Cinctive Capital Management LP increased its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 717.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,398 shares of the biotechnologApril 4, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Stock Position Lifted by Alliancebernstein L.P.Alliancebernstein L.P. grew its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 23.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,010,896 shares of the biotechnology company's stock after acquiring an additionaApril 3, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Shares Sold by Prudential Financial Inc.Prudential Financial Inc. decreased its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 45.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,641 shares of the biotechnology company's sApril 3, 2025 | marketbeat.comGroupama Asset Managment Grows Holdings in Repligen Co. (NASDAQ:RGEN)Groupama Asset Managment boosted its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 12,321.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 403,932 shares of the biotechnology company's stock after purchasing an additional 400,680 shApril 2, 2025 | marketbeat.comVanguard Group Inc. Acquires 56,723 Shares of Repligen Co. (NASDAQ:RGEN)Vanguard Group Inc. grew its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 1.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,101,090 shares of the biotechnology company's stock after acquirinApril 1, 2025 | marketbeat.comPremier Fund Managers Ltd Takes Position in Repligen Co. (NASDAQ:RGEN)Premier Fund Managers Ltd acquired a new position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,113 shares of the biotechnology company's stocMarch 30, 2025 | marketbeat.comKLP Kapitalforvaltning AS Acquires Shares of 10,800 Repligen Co. (NASDAQ:RGEN)KLP Kapitalforvaltning AS bought a new position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 10,800 shares of the biotechnology cMarch 30, 2025 | marketbeat.comTeacher Retirement System of Texas Purchases 6,805 Shares of Repligen Co. (NASDAQ:RGEN)Teacher Retirement System of Texas lifted its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 229.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,775 shares of the biotechnMarch 30, 2025 | marketbeat.comArtisan Partners Limited Partnership Has $59.56 Million Stake in Repligen Co. (NASDAQ:RGEN)Artisan Partners Limited Partnership reduced its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 5.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 413,747 shares of the biotechnolMarch 29, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Stock Holdings Lowered by Corebridge Financial Inc.Corebridge Financial Inc. cut its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 59,054 shares of the biotechnology company's stock after selling 2,March 29, 2025 | marketbeat.comAmerican Century Companies Inc. Has $40.54 Million Stake in Repligen Co. (NASDAQ:RGEN)American Century Companies Inc. reduced its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 2.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 281,658 shares of the biotechnology company's stoMarch 29, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Repligen Co. (NASDAQ:RGEN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eMarch 28, 2025 | marketbeat.comZions Bancorporation N.A. Has $2.03 Million Stake in Repligen Co. (NASDAQ:RGEN)Zions Bancorporation N.A. grew its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 48.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,079 shares of the biotechnology company's stock after purchasing an additional 4,626 shMarch 27, 2025 | marketbeat.comEFG Asset Management North America Corp. Decreases Stake in Repligen Co. (NASDAQ:RGEN)EFG Asset Management North America Corp. lessened its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 13.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,297 shares of the biotechMarch 27, 2025 | marketbeat.com132,143 Shares in Repligen Co. (NASDAQ:RGEN) Bought by Segall Bryant & Hamill LLCSegall Bryant & Hamill LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 132,143 shares of the biotechMarch 27, 2025 | marketbeat.comSei Investments Co. Has $31.61 Million Stake in Repligen Co. (NASDAQ:RGEN)Sei Investments Co. lifted its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 12.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 219,604 shares of the biotechnology company's stock after buying an additional 24,6March 26, 2025 | marketbeat.comIs Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management?March 25, 2025 | insidermonkey.comRepligen Co. (NASDAQ:RGEN) Shares Sold by Zevenbergen Capital Investments LLCZevenbergen Capital Investments LLC lessened its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 12.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 112,747 shares of the biotechnology company's stock after selling 16March 25, 2025 | marketbeat.com4,635 Shares in Repligen Co. (NASDAQ:RGEN) Purchased by Fox Run Management L.L.C.Fox Run Management L.L.C. purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 4,635 shares of the biotechnology company's stock, valued at approximately $667,000.March 25, 2025 | marketbeat.comNatixis Advisors LLC Purchases 10,692 Shares of Repligen Co. (NASDAQ:RGEN)Natixis Advisors LLC boosted its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 31.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,317 shares of the biotechnology company's stock after buyMarch 23, 2025 | marketbeat.comInsider Buying: Margaret Pax Acquires Shares of Repligen Corp (RGEN)March 21, 2025 | gurufocus.comRepligen’s SWOT analysis: bioprocessing leader’s stock faces growth and valuation challengesMarch 21, 2025 | uk.investing.comRepligen Co. (NASDAQ:RGEN) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA cut its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 43.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,858 shares of the biotechnology company's stock after sellingMarch 21, 2025 | marketbeat.comRepligen: Ongoing Bioprocessing Market RecoveryMarch 20, 2025 | seekingalpha.comThrivent Financial for Lutherans Sells 33,482 Shares of Repligen Co. (NASDAQ:RGEN)Thrivent Financial for Lutherans lessened its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 5.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 605,120 shares of the biotechnology company's stock after selling 33,482 shares during thMarch 20, 2025 | marketbeat.comRepligen Director Makes a Multi-Million Dollar Stock Move!March 19, 2025 | tipranks.comRepligen Co. (NASDAQ:RGEN) Director Margaret Pax Purchases 250 SharesRepligen Co. (NASDAQ:RGEN - Get Free Report) Director Margaret Pax bought 250 shares of the stock in a transaction on Monday, March 17th. The shares were acquired at an average cost of $150.69 per share, for a total transaction of $37,672.50. Following the completion of the transaction, the director now directly owns 1,043 shares of the company's stock, valued at approximately $157,169.67. The trade was a 31.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 19, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Shares Gap Down - Here's What HappenedRepligen (NASDAQ:RGEN) Shares Gap Down - Here's What HappenedMarch 19, 2025 | marketbeat.comEvercore ISI Begins Coverage on Repligen (NASDAQ:RGEN)Evercore ISI assumed coverage on shares of Repligen in a report on Tuesday. They set an "in-line" rating and a $155.00 price target on the stock.March 19, 2025 | marketbeat.com Remove Ads Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address RGEN Media Mentions By Week RGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGEN News Sentiment▼0.890.80▲Average Medical News Sentiment RGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGEN Articles This Week▼128▲RGEN Articles Average Week Remove Ads Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News United Therapeutics News Incyte News BioMarin Pharmaceutical News Exelixis News Neurocrine Biosciences News Exact Sciences News Halozyme Therapeutics News Madrigal Pharmaceuticals News Ionis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGEN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RGEN Stock Free RGEN Stock Alerts